These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27986495)
1. Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy. Elborn JS; Davies J; Mall MA; Flume PA; Plant B J Cyst Fibros; 2017 Jan; 16(1):163-164. PubMed ID: 27986495 [TBL] [Abstract][Full Text] [Related]
2. [Cystic fibrosis: new treatments targeting the CFTR protein]. Fajac I; Sermet-Gaudelus I Rev Mal Respir; 2013 Apr; 30(4):255-61. PubMed ID: 23664284 [TBL] [Abstract][Full Text] [Related]
3. New and emerging targeted therapies for cystic fibrosis. Quon BS; Rowe SM BMJ; 2016 Mar; 352():i859. PubMed ID: 27030675 [TBL] [Abstract][Full Text] [Related]
4. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein]. Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675 [TBL] [Abstract][Full Text] [Related]
5. The influence of CFTR complex alleles on precision therapy of cystic fibrosis. Chevalier B; Hinzpeter A J Cyst Fibros; 2020 Mar; 19 Suppl 1():S15-S18. PubMed ID: 31883651 [TBL] [Abstract][Full Text] [Related]
6. New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator. Ong T; Ramsey BW Pediatr Clin North Am; 2016 Aug; 63(4):751-64. PubMed ID: 27469186 [TBL] [Abstract][Full Text] [Related]
7. Translational research to enable personalized treatment of cystic fibrosis. Hagemeijer MC; Siegwart DJ; Strug LJ; Cebotaru L; Torres MJ; Sofoluwe A; Beekman JM J Cyst Fibros; 2018 Mar; 17(2S):S46-S51. PubMed ID: 29275953 [TBL] [Abstract][Full Text] [Related]
8. Repairing the basic defect in cystic fibrosis - one approach is not enough. Farinha CM; Matos P FEBS J; 2016 Jan; 283(2):246-64. PubMed ID: 26416076 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic advances in cystic fibrosis in 2014]. Durupt S; Mazur S; Reix P Rev Pneumol Clin; 2016 Feb; 72(1):77-86. PubMed ID: 25727661 [TBL] [Abstract][Full Text] [Related]
13. New treatments targeting the basic defects in cystic fibrosis. Fajac I; Wainwright CE Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723 [TBL] [Abstract][Full Text] [Related]
14. New horizons for cystic fibrosis treatment. Fajac I; De Boeck K Pharmacol Ther; 2017 Feb; 170():205-211. PubMed ID: 27916649 [TBL] [Abstract][Full Text] [Related]
15. Progress in therapies for cystic fibrosis. De Boeck K; Amaral MD Lancet Respir Med; 2016 Aug; 4(8):662-674. PubMed ID: 27053340 [TBL] [Abstract][Full Text] [Related]
16. Advances in the diagnosis and treatment of cystic fibrosis. Martiniano SL; Hoppe JE; Sagel SD; Zemanick ET Adv Pediatr; 2014 Aug; 61(1):225-43. PubMed ID: 25037130 [TBL] [Abstract][Full Text] [Related]
17. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis. Villate-Beitia I; Zarate J; Puras G; Pedraz JL Drug Dev Ind Pharm; 2017 Jul; 43(7):1071-1081. PubMed ID: 28270008 [TBL] [Abstract][Full Text] [Related]
18. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects. Kuk K; Taylor-Cousar JL Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827 [TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis research topics featured at the 14th ECFS Basic Science Conference: Chairman's summary. Mall MA; Hwang TC; Braakman I J Cyst Fibros; 2018 Mar; 17(2S):S1-S4. PubMed ID: 29229473 [TBL] [Abstract][Full Text] [Related]
20. [Challenges of personalized medicine for cystic fibrosis]. Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]